Peptide derivatives

Details Peptide derivatives Peptide derivatives

2006-01-10

2006-01-10

Celsa, Bennett (Department: 1639)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S018700, C514S315000, C514S326000

Reexamination Certificate

active

06984627

ABSTRACT:
Pharmaceutical preparation containing an effective amount of acetylsalicylic acid and a compound of Formula I.in-line-formulae description="In-line Formulae" end="lead"?A1—A2—NH—(CH2)n—Bin-line-formulae description="In-line Formulae" end="tail"?wherein A1, A2, n and B are as defined in the specification, which is either the compound as such, or a stereoisomer thereof, and which may be in the form of a physiologically acceptable salt, in association with a pharmaceutical carrier. The combinations are suitable for use in inhibiting thrombin, or in the treatment or prophylaxis of thrombosis or hypercoagulability in patients in need thereof.

REFERENCES:
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 4568636 (1986-02-01), Svendsen
patent: 4703036 (1987-10-01), Bajusz et al.
patent: 4977168 (1990-12-01), Bernat et al.
patent: 5037819 (1991-08-01), Han
patent: 5110812 (1992-05-01), Han
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5273982 (1993-12-01), Alig et al.
patent: 5583146 (1996-12-01), Kimball et al.
patent: 5614499 (1997-03-01), Bylund et al.
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5744487 (1998-04-01), Ohshima et al.
patent: 5783563 (1998-07-01), Antonsson et al.
patent: 5795896 (1998-08-01), Lofroth et al.
patent: 5830865 (1998-11-01), Stjernfelt et al.
patent: 5856307 (1999-01-01), Antonsson et al.
patent: 5880136 (1999-03-01), Duggan et al.
patent: 5939392 (1999-08-01), Antonsson et al.
patent: 5965692 (1999-10-01), Gustafsson et al.
patent: 6262028 (2001-07-01), Antonsson et al.
patent: 0074787 (1983-03-01), None
patent: 0 074 787 (1983-03-01), None
patent: 0 192 135 (1986-03-01), None
patent: 0192135 (1986-03-01), None
patent: 0 185 390 (1986-06-01), None
patent: 0 195 212 (1986-09-01), None
patent: 0 235 692 (1987-09-01), None
patent: 0235692 (1987-09-01), None
patent: 0 236 163 (1987-09-01), None
patent: 0 293 881 (1988-06-01), None
patent: 0 362 002 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0479489 (1991-09-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0471651 (1992-02-01), None
patent: 0 478 362 (1992-04-01), None
patent: 0 513 543 (1992-11-01), None
patent: 0 513 543 (1992-11-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 530 167 (1993-03-01), None
patent: 0 530 167 (1993-03-01), None
patent: 0530167 (1993-03-01), None
patent: 0 542 525 (1993-05-01), None
patent: 0 542 525 (1993-05-01), None
patent: 0 559 046 (1993-09-01), None
patent: 0 641 779 (1995-03-01), None
patent: 0 648 780 (1995-04-01), None
patent: 0 669 317 (1995-08-01), None
patent: 2085444 (1982-04-01), None
patent: 2 085 444 (1982-04-01), None
patent: 2 161 801 (1986-01-01), None
patent: 9204371 (1992-03-01), None
patent: 9 204 371 (1992-03-01), None
patent: 9208709 (1992-03-01), None
patent: 9207869 (1992-05-01), None
patent: WO 93/11152 (1993-06-01), None
patent: WO 93/18060 (1993-09-01), None
Honour et al. , British Journal of Experimental Pathology (1977) vol. 58, No. 5, pp. 474-477.
Biosis Abstract No. 1978:223366 to Honour et al. Br. J. Exp. Pathol. (1977) vol. 58 (5) pp. 474-477.
Stewart et al: “Solid Phase Peptide Synthesis,” Pierce Chemical Company, pp. 18-20 (with appendix).
Bajusz: “Interaction of Trypsin-like Enzymes With Small Inhibitors,” pp. 277-298,Symposia Biologica Hungarica 25(1984).
Jackson et al, “Pharmacological Assessment of the Antithrombotic Activity . . . ” J. of Pharm. Exp. Ther.261: 546-552, 1992.
Knabb et al, “In Vivo Characterization of a New Synthetic Thrombin Inhibitor,” Thrombosis and Haemostasis, 67(1): 56-59, 1992.
Bajusz et al, “Inhibition of Thrombin with H- and Boc-D-Phe-Pro-Agm,” Chem. Abs. 99:205609W, 1983.
Klement et al, “The Effect of Thrombin Inhibitors on Tissue Plasminogen . . . ” Thrombosis and Haemostasis, 68(1): 64-68, 1992.
Marki et all, “The Anticoagulant and Antithrombotic Properties of Hirudins . . . ” Thrombosis and Haemostasis, 64(3): 344-348, 1990.
Broersma et al, “The Effect of Thrombin Inhibition in a Rat . . . ,” Thrombosis Research, 64: 405-412, 1991.
Persson et al, Thorax, 47: 993-1000, 1992.
Salomonson et al, Am. Rev. Resp. Dis. 146:1535-1542, 1992.
Markwardt et al, Biochem. Pharm. 23: 2247-2256, 1974.
Malek et al, “Palladium-catalyzed synthesis of Cinnamylamides,” J. Org. Chem. 47(27): 5395-5397, 1982.
Malek, et al, Chem. Abs. 98:16353, 1983.
Chung et al, J. Organic Chem. 1: 270-275.
Glusa et al, “The influence of benzamidine . . . ,” Thrombosis et Diathesis Haemorrhagica 31:172-178, 1974.
Anderson and Lok, J. Organic Chem. 37:3953, 1972.
Fareed et al, Ann, N.Y. Acad. Sci. 370: 765-784, 1981.
Geratz, J.D., “Inhibition of thrombin, plasmin . . . ” Thrombosis et Diathesis Halmorrhagica 23(3), 486-499 (1970).
Stewart et al, “Solid Phase Peptide Synthesis,” Pierce Chemical Company, pp. 18-20 (with appendix).
Bajusz, “Interaction of Trypsin-like Enzymes with Small Inhibitors,” pp. 277-298, Symposia Biologica Hungarica 25 (1984).
Jackson et al, “Pharmacological Assessment of the Antithrombotic . . . ” J. of Pharm. Exp. Ther.261: 546-552, 1992.
Knabb et al, “In Vivo Characterization of a New Synthetic . . . ” Thrombosis and Haemostasis, vol. 67 No. 1, pp. 56-59 (1992).
Bajusz et al, “Inhibition of Thrombin with H- and Boc-D-Phe-Pro-Agm,” Chem. Abs. 99: 205609W (1983).
Klement et al, “The Effect of Thrombin Inhibitors on Tissue Plasminogen . . . ,” Thrombosis and Haemostasis, vol. 68, No. 1, pp. 64-68 (1992).
Marki et al, “The Anticoagulant and Antithrombotic . . . ,” Thrombosis and Haemostasis, vol. 64, No. 3, pp. 344-348 (1990).
Broersma et al, “The Effect of Thrombin Inhibition in a Rat Arterial . . . ,” Thrombosis Research, vol. 64, pp. 405-412 (1991).
Persson et al, Thorax, vol. 47, pp. 993-1000 (1992).
Salomonson et al, Am. Rev. Resp. Dis., vol. 146, 1535-1542 (1992).
Markwardt et al, Biochem. Pharm., vol. 23, pp. 2247-2256 (1974).
Malek et al, “Palladium-catalyzed synthesis” J. Org. Chem., vol. 47, No. 27, 5395-5397 (1982).
Malek et al, Chem. Abs. 98: 16353 (1983).
Chung et al, J. Organic Chem. vol. 1, pp. 270-275.
Glusa et al, “The influence of benzamidine derivatives . . . ,” Thrombosis et Diathesis Haemorrhagica, vol. 31, pp. 172-178 (1974).
Anderson and Lok, J. Organic Chem., vol. 37, p. 3953 (1972).
Fareed et al, Ann. N.Y. Acad. Sci., vol. 370, pp. 765-784 (1981).
Geratz, J.D., “Inhibition of thrombin, plasmin and plasminogen compounds,” Thrombosis et Diathesis Halmorrhagica, vol. 23, No. 3, pp. 486-499 (1970).
Claeson, G.; “Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Proteases in the Blood Coagulation System”;Blood Coagulation and Fibrinolysis; vol. 5; pp 411-436 (1994).
Blomback, B., et al; “Synthetic Peptides and Aticoagulant and Vasodilating Activity”,Clin. Lab. Invest.; vol. 24, Suppl. pp. 107-59 (1969).
Abdel-Wahab, A.A.; “Modern Friedel-Crafts Chemistry. XI. Cyclization of Aryl Haloalkyl Sulfones, Arylsulfonylacyl Chlorides and Their Corresponding Sulfides”;Phosphorous and Suflur, vol. 19; pp. 31-44 (1984).
Stephan, D., et al; “Effect of Tertatolol and of Its Metabolites and Structural Analogues in Isolated Perfused Rat Kidney Vasculature”;Journal of Cardiovascular Pharmacology; vol. 16 pp. 338-346 (1990).
Ofosu, F.A., et al; “Inhibition of Factor X and Factor V Activation by Dermatan Sulfate and a Pentasaccharide with High affinity for Antithrombin III in Human Plasma”;Eur. J. Biochem; vol. 193; pp. 485-493 (1990).

Affiliated with

Also associated with

Rating

Peptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569556